Kevin J Yeaman
CEO, President at Dolby Laboratories, Inc. (DLB)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $8.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 21,772110,122 held (−17%) | $66.64 | $1.5M | -11.9% |
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 4,994105,128 held (−5%) | $67.16 | $335K | -12.5% |
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 6,67198,457 held (−6%) | $67.24 | $449K | -12.6% |
| Dec 17SEC | DLBDolby Laboratories, Inc. | Sell Plan | 8098,377 held (−0%) | $67.54 | $5K | -13.0% |
| Dec 11SEC | DLBDolby Laboratories, Inc. | Sell Plan | 28,168104,576 held (−21%) | $66.99 | $1.9M | -12.3% |
| Dec 11SEC | DLBDolby Laboratories, Inc. | Sell Plan | 6,19998,377 held (−6%) | $67.51 | $418K | -13.0% |
| Nov 26SEC | DLBDolby Laboratories, Inc. | Sell Plan | 36,699114,725 held (−24%) | $66.91 | $2.5M | -12.2% |
| Oct 16SEC | DLBDolby Laboratories, Inc. | Sell Plan | 11,214128,511 held (−8%) | $68.51 | $768K | -14.3% |
| Oct 16SEC | DLBDolby Laboratories, Inc. | Sell Plan | 13,786114,725 held (−11%) | $69.17 | $954K | -15.1% |
- Sell
CEO, President Kevin J Yeaman sold $1.5M of DLB at $66.64 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Kevin J Yeaman sold $335K of DLB at $67.16 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Kevin J Yeaman sold $449K of DLB at $67.24 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Kevin J Yeaman sold $5K of DLB at $67.54 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Kevin J Yeaman sold $1.9M of DLB at $66.99 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Kevin J Yeaman sold $418K of DLB at $67.51 — pre-scheduled 10b5-1 plan sale.